Press Release
Home > Press Release > PR Newswire
Genomma Lab Reaffirms Zero Ownership Stake in the Laser Hair Removal Chains Neoskin and Depilite
Font Scale: 
MEXICO CITY, Nov. 11 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. deC.V. (BMV: LAB) ("Genomma" or "the Company"), a leading Mexicanover-the-counter ("OTC") pharmaceuticals and personal care products companyannounced today that it owns no shares in the laser hair removal chain"Neoskin," which has recently been the subject of negative news reports.Furthermore, Genomma reiterates that in March 2008, it divested all its sharesof Global Administrator, S.A. de C.V., the firm which independently operatesvarious companies, including the stores that offer laser hair removal servicesunder the brand "Depilite."
Genomma Lab announces the above in order to clarify its disassociationwith these operations and reiterates that it has no plans to participate inthe laser hair removal business in the future.
The Company continues with its current business plan and expects tocommunicate its 2009 growth plans in the coming weeks.
Company Description
Genomma Lab Internacional, S.A.B. de C.V. is one of the fastest growingover-the-counter pharmaceutical and personal care products companies inMexico, and has a growing international presence. Genomma develops, sells andmarkets a broad range of premium branded products, many of which are leadersin the categories in which they compete in terms of sales and market share.
Genomma Lab performed its Initial Public Offering in June, 2008, through acombined offering (mainly primary) and is listed on the Mexican Stock Exchangeunder the ticker symbol "LAB.B" (Bloomberg: labb.mx).
In its third quarter report of 2008, Genomma Lab reported Sales for thefirst nine months of 2008 of Ps. $ 1,891 million, an EBITDA of Ps. $ 470million, a Net Consolidated Income of Ps. $ 320 million and cash andequivalents of Ps. $ 1,073 million.
Web Site: www.genommalab.com
SOURCE Genomma Lab Internacional, S.A.B. de C.V.
The Company continues with its current business plan and expects tocommunicate its 2009 growth plans in the coming weeks.
Company Description
Genomma Lab Internacional, S.A.B. de C.V. is one of the fastest growingover-the-counter pharmaceutical and personal care products companies inMexico, and has a growing international presence. Genomma develops, sells andmarkets a broad range of premium branded products, many of which are leadersin the categories in which they compete in terms of sales and market share.
Genomma Lab performed its Initial Public Offering in June, 2008, through acombined offering (mainly primary) and is listed on the Mexican Stock Exchangeunder the ticker symbol "LAB.B" (Bloomberg: labb.mx).
In its third quarter report of 2008, Genomma Lab reported Sales for thefirst nine months of 2008 of Ps. $ 1,891 million, an EBITDA of Ps. $ 470million, a Net Consolidated Income of Ps. $ 320 million and cash andequivalents of Ps. $ 1,073 million.
Web Site: www.genommalab.com
SOURCE Genomma Lab Internacional, S.A.B. de C.V.
For more iinformation, go to www.prnewswire.com
- Sponsored By
-
Recent Press Release
Advertisement
POS Magnetic Card Readers
Online distributor for point of sale equipment, TYSSO and Pegasus.
